Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
New Microbes and New Infections
|
July 28, 2020
Endophthalmitis resulting from gonococcal keratoconjunctivitis
R Bollam, M Yassin, T Phan
Current Neurology and Neuroscience Reports
|
March 12, 2018
When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM
Saumya R Bollam, Michael E Berens, Harshil D Dhruv
The International Journal of Biological Markers
|
February 15, 2011
Evaluation of serum human telomerase reverse transcriptase as a novel marker for cervical cancer
Mahendar Porika, Radhika Tippani, Anwar Mohammad, et al.
International Journal of Clinical Oncology
|
April 29, 2011
Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis
Mahendar Porika, Radhika Tippani, Sekhar R Bollam, et al.
Developmental Cell
|
November 8, 2016
Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression
Yuhao Shi, Saumya R Bollam, Shannon M White, et al.
Nature Communications
|
July 14, 2021
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
Wei-Ching Chen, Minh D To, Peter M K Westcott, et al.
Science (New York, N.Y.)
|
May 30, 2024
Stem-cell states converge in multistage cutaneous squamous cell carcinoma development
Mark A Taylor, Eve Kandyba, Kyle Halliwill, et al.
Plos Pathogens
|
October 28, 2020
Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
Emily D Crawford, Irene Acosta, Vida Ahyong, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
New Microbes and New Infections
|
July 28, 2020
Endophthalmitis resulting from gonococcal keratoconjunctivitis
R Bollam, M Yassin, T Phan
Current Neurology and Neuroscience Reports
|
March 12, 2018
When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM
Saumya R Bollam, Michael E Berens, Harshil D Dhruv
The International Journal of Biological Markers
|
February 15, 2011
Evaluation of serum human telomerase reverse transcriptase as a novel marker for cervical cancer
Mahendar Porika, Radhika Tippani, Anwar Mohammad, et al.
International Journal of Clinical Oncology
|
April 29, 2011
Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis
Mahendar Porika, Radhika Tippani, Sekhar R Bollam, et al.
Developmental Cell
|
November 8, 2016
Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression
Yuhao Shi, Saumya R Bollam, Shannon M White, et al.
Nature Communications
|
July 14, 2021
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
Wei-Ching Chen, Minh D To, Peter M K Westcott, et al.
Science (New York, N.Y.)
|
May 30, 2024
Stem-cell states converge in multistage cutaneous squamous cell carcinoma development
Mark A Taylor, Eve Kandyba, Kyle Halliwill, et al.
Plos Pathogens
|
October 28, 2020
Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
Emily D Crawford, Irene Acosta, Vida Ahyong, et al.
Page
of 1